LCM
ASTX

LionEye Capital Management’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

LionEye Capital Management’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-300,000
Closed -$2.55M – 79
2013
Q3 		$2.55M Buy
+300,000
New +$1.9M 0.56% 49

LionEye Capital Management's ASTX Position: Q4 2013 in Review

LionEye Capital Management sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 300,000 shares — an estimated $2.55M sold.

LionEye Capital Management first reported a position in ASTX in Q3 2013 and held it in 1 quarter. The position peaked at $2.55M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • LionEye Capital Management reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • LionEye Capital Management sold 300,000 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $2.55M.
  • LionEye Capital Management first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q3 2013 and held it in 1 quarter.
  • LionEye Capital Management's ASTEX PHARMACEUTICALS, INC COM position peaked at $2.55M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on LionEye Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.